These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11598833)

  • 1. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
    Kishihara Y; Furusyo N; Kashiwagi K; Mitsutake A; Kashiwagi S; Hayashi J
    J Infect Dis; 2001 Nov; 184(9):1114-9. PubMed ID: 11598833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
    Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
    Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
    Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
    J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
    de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
    Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
    J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leprosy and confinement due to leprosy show high association with hepatitis C in Southern Brazil.
    de Moraes Braga AC; Reason IJ; Maluf EC; Vieira ER
    Acta Trop; 2006 Jan; 97(1):88-93. PubMed ID: 16263074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
    J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher clearance of hepatitis C virus infection in females compared with males.
    Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A
    Gut; 2006 Aug; 55(8):1183-7. PubMed ID: 16434426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.
    Treviño A; García J; de Mendoza C; Benito R; Aguilera A; Ortíz de Lejarazu R; Ramos JM; Trigo M; Eirós JM; Rodríguez-Iglesias M; Torres A; Calderón E; Hernandez A; Gomez C; Marcaida G; Soriano V;
    AIDS Res Hum Retroviruses; 2010 Aug; 26(8):861-4. PubMed ID: 20672999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma.
    Kamihira S; Yamada Y; Sohda H; Atogami S; Tomonaga M; Egawa S; Fujii M; Chifu K
    Cancer Detect Prev; 1994; 18(5):329-34. PubMed ID: 7812978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.
    Boschi-Pinto C; Stuver S; Okayama A; Trichopoulos D; Orav EJ; Tsubouchi H; Mueller N
    J Infect Dis; 2000 Jan; 181(1):35-41. PubMed ID: 10608748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus reinfection in injection drug users.
    Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
    Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.